Blood collection is a medical process that saves lot of time and offers doctors to immediately deliver and monitor the diseases. Blood collection samples process is a regularly used technique to track the severe as well as mild diseases. Earlier, the collection of blood was a painful and a time-consuming procedure. Hence, the improved blood collection method used today overcomes all of the above mentioned challenges. Blood collection and its results help reveal the medical condition of the patient, his overall condition, and disclose more about specific conditions. A normal health checkup generally comprises blood collection, which is essential and a beneficial tool to control and regulate the medical condition of the patient.
Blood collection market accounted forover US$ 8.9 billion in 2019. It is anticipated to grow at a CAGR of ~5.2% from 2020 to 2030.
The first step in acquiring a quality lab test result for any patient is the specimen collection or blood collection procedure. The global blood collection market is growing at a stable pace and is expected to continue growing steadily during the forecast period. The factors which can be attributed to the growth of this market are rising incidences of accidents & trauma cases globally, increasing cases of ailments that require blood diagnosis, initiatives by both private & public bodies to promote blood donations, rising demand for blood components, among others. However, factors such as the outbreak of infectious diseases, such as the current global COVID-19 pandemic, is expected to hamper the growth of this market immensely.
The prominent players operating in the global blood collection market are:
Terumo Medical Corporation, Medtronic, BD, Fresenius Kabi AG (Fresenius Health Care Group), Grifols, S.A., FL MEDICAL s.r.l., Haemonetics Corporation, Greiner Bio One International GmbH, Smiths Medical (Smiths Group plc.), KAWASUMI LABORATORIES. INC., among others.
No comments:
Post a Comment